EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62020CN0400
Case C-400/20 P: Appeal brought on 21 August 2020 by Dermavita Co. Ltd against the judgment of the General Court (Third Chamber) delivered on 25 June 2020 in Case T-104/19, Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
Case C-400/20 P: Appeal brought on 21 August 2020 by Dermavita Co. Ltd against the judgment of the General Court (Third Chamber) delivered on 25 June 2020 in Case T-104/19, Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
Case C-400/20 P: Appeal brought on 21 August 2020 by Dermavita Co. Ltd against the judgment of the General Court (Third Chamber) delivered on 25 June 2020 in Case T-104/19, Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
OJ C 35, 1.2.2021, p. 21–22
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
1.2.2021 |
EN |
Official Journal of the European Union |
C 35/21 |
Appeal brought on 21 August 2020 by Dermavita Co. Ltd against the judgment of the General Court (Third Chamber) delivered on 25 June 2020 in Case T-104/19, Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
(Case C-400/20 P)
(2021/C 35/32)
Language of the case: English
Parties
Appellant: Dermavita Co. Ltd (represented by: D. Todorov, адвокат)
Other parties to the proceedings: European Union Intellectual Property Office, Allergan Holdings France
By order of 3 December 2020, the Court of Justice (Chamber determining whether appeals may proceed) decided that the appeal should not be allowed to proceed and ordered the appellant to bear its own costs.